Tarín et al. [13] showed that relapsed/refractory MM (RRMM) patients exhibit lower CD27 and higher CD81 expression, while Pojero et al. [27] showed that progressive MM has lower CD27 expression. This evidence concerns the gene CD27 and Miyoshi myopathy.